Paragraph IV Certifications: How Generic Drug Makers Legally Challenge Brand Patents
Paragraph IV certifications let generic drug makers legally challenge brand-name patents before market entry. This Hatch-Waxman tool drives competition, lowers drug prices, and offers 180-day exclusivity to the first challenger.
Read More